Liquidia Technologies
Presence
Liquidia Technologies is one of the...
Liquidia Technologies is a company listed under the stock ticker LQDA (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Liquidia Technologies
- Roger Jeffs, Chief Executive Officer and Director
- Stephen Bloch, Chairman of the Board
- Damian Degoa, Director
Popular executive movements at Liquidia Technologies
- Michael Kaseta, who was Chief Financial Officer, is promoted to Chief Financial Officer and Chief Operating Officer (posted on January 21 2024).
Create your alert
to follow the executive moves at Liquidia Technologies.
Pharmaceuticals
Liquidia Technologies has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Liquidia Technologies
- Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022 | Liquidia
- Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022 | Liquidia
- Liquidia to Participate in Upcoming Investor Conferences | Liquidia
- Liquidia Announces the Publication of Long-Term Clinical Data from Completed INSPIRE Study in the Journal Pulmonary Circulation | Liquidia
- Liquidia Announces the Publication of Long-Term Clinical Data from Completed INSPIRE Study in the Journal Pulmonary Circulation | Liquidia
- Liquidia to Participate in Upcoming Investor Conferences | Liquidia
- Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | Liquidia
- Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | Liquidia
- Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent | Liquidia
- Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent | Liquidia
- View more press releases Close
Social media about Liquidia Technologies
- Liquidia Technologies on Wikipedia, Google News & Yahoo Finance
- Liquidia Technologies on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Roger Jeffs 
Call Liquidia Technologies at +1 919...
